PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummaryFeb 5, 2003	Integra LifeSciences Announces CE Mark for the NeuraGenT Nerve Guide for Repair of Severed Peripheral Nerves Integra LifeSciences Announces CE Mark for the NeuraGenT Nerve Guide for Repair of Severed Peripheral Nerves Plainsboro, New Jersey, February 5, 2003-- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that it has received the CE mark for the NeuraGenT Nerve Guide, an	View HTML Integra LifeSciences Announces CE Mark for the NeuraGenT Nerve Guide for Repair of Severed Peripheral Nerves 12.5 KB
Toggle SummaryFeb 19, 2003	Integra LifeSciences Schedules Conference Call for Thursday, February 27 to Discuss Fourth Quarter and Full Year 2002 Financial Results and Update Forward-Looking Financial Guidance Integra LifeSciences Schedules Conference Call for Thursday, February 27 to Discuss Fourth Quarter and Full Year 2002 Financial Results and Update Forward-Looking Financial Guidance PLAINSBORO, N.J.-February 19, 2003-- Integra LifeSciences Holdings Corporation (NASDAQ: IART - news) announced that	View HTML Integra LifeSciences Schedules Conference Call for Thursday, February 27 to Discuss Fourth Quarter and Full Year 2002 Financial Results and Update Forward-Looking Financial Guidance 10.3 KB
Toggle SummaryFeb 27, 2003	Integra LifeSciences Reports Record Earnings and Revenues for the Fourth Quarter and Full Year 2002 Integra LifeSciences Reports Record Earnings and Revenues for the Fourth Quarter and Full Year 2002 Click here for release.	View HTML Integra LifeSciences Reports Record Earnings and Revenues for the Fourth Quarter and Full Year 2002 7.7 KB
Toggle SummaryMar 18, 2003	Integra LifeSciences Announces Acquisition of JARIT Surgical Instruments; Raises Revenue and Earnings Guidance Integra LifeSciences Announces Acquisition of JARIT Surgical Instruments; Raises Revenue and Earnings Guidance Plainsboro, NJ / March 18, 2003 / -- Integra LifeSciences Holdings Corporation (NASDAQ: IART - news) announced today that it has acquired JARIT&reg; Surgical Instruments for	View HTML Integra LifeSciences Announces Acquisition of JARIT Surgical Instruments; Raises Revenue and Earnings Guidance 15.1 KB
Toggle SummaryMar 26, 2003	Integra LifeSciences Confirms Earnings Guidance Integra LifeSciences Confirms Earnings Guidance Plainsboro, NJ / March 26, 2003 / -- Integra LifeSciences Holdings Corporation (NASDAQ: IART - news) announced today that the Company's guidance for earnings per share of $0.16 for the first quarter of 2003 remains unchanged.	View HTML Integra LifeSciences Confirms Earnings Guidance 10.5 KB
Toggle SummaryMar 26, 2003	Integra LifeSciences Holdings Corporation to Sell $100 Million of Contingent Convertible Subordinated Notes Integra LifeSciences Holdings Corporation to Sell $100 Million of Contingent Convertible Subordinated Notes Plainsboro, New Jersey - March 26, 2003 - Integra LifeSciences Holdings Corporation (Nasdaq: IART) announced that it has agreed to sell $100 million principal amount of its 2.5% contingent	View HTML Integra LifeSciences Holdings Corporation to Sell $100 Million of Contingent Convertible Subordinated Notes 10.5 KB
Toggle SummaryApr 9, 2003	Integra LifeSciences Schedules Conference Call for Friday, April 25 to Discuss First Quarter 2003 Financial Results and Update Forward-Looking Financial Guidance Integra LifeSciences Schedules Conference Call for Friday, April 25 to Discuss First Quarter 2003 Financial Results and Update Forward-Looking Financial Guidance PLAINSBORO, N.J.-April 9, 2003-- Integra LifeSciences Holdings Corporation (NASDAQ: IART - news) announced that it has scheduled a	View HTML Integra LifeSciences Schedules Conference Call for Friday, April 25 to Discuss First Quarter 2003 Financial Results and Update Forward-Looking Financial Guidance 10.3 KB
Toggle SummaryApr 16, 2003	Integra LifeSciences Holdings Corporation to Sell Additional $20 Million of Contingent Convertible Subordinated Notes Integra LifeSciences Holdings Corporation to Sell Additional $20 Million of Contingent Convertible Subordinated Notes Plainsboro, New Jersey - April 11, 2003 - Integra LifeSciences Holdings Corporation (Nasdaq: IART) announced that the initial purchasers of its 2.5% Contingent Convertible	View HTML Integra LifeSciences Holdings Corporation to Sell Additional $20 Million of Contingent Convertible Subordinated Notes 10.3 KB
Toggle SummaryApr 25, 2003	Integra LifeSciences Reports Record Pre-Tax Earnings and Revenues for the First Quarter 2003 Integra LifeSciences Reports Record Pre-Tax Earnings and Revenues for the First Quarter 2003 Cash Flows from Operations Totaled $8.8 Million PLAINSBORO, N.J., April 25, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (NasdaqNM: IART - News) today reported net income of $5.4 million,	View HTML Integra LifeSciences Reports Record Pre-Tax Earnings and Revenues for the First Quarter 2003 20.9 KB
Toggle SummaryApr 30, 2003	Investigators Present Results of Brain Tissue Oxygen Monitoring Clinical Experience at AANS 2003 Annual Meeting In San Diego Investigators Present Results of Brain Tissue Oxygen Monitoring Clinical Experience at AANS 2003 Annual Meeting In San Diego Plainsboro, New Jersey, April 29, 2003-- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that members of the Department of Neurosurgery and Surgery	View HTML Investigators Present Results of Brain Tissue Oxygen Monitoring Clinical Experience at AANS 2003 Annual Meeting In San Diego 12.1 KB
Toggle SummaryApr 30, 2003	Integra LifeSciences announces 1000th implant of NeuraGen™ Nerve Guide for Peripheral Nerve Repair Integra LifeSciences announces 1000th implant of NeuraGenÔ Nerve Guide for Peripheral Nerve Repair Plainsboro, NJ / April 29, 2003 / -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today reported that more than 1,000 NeuraGenÔ Nerve Guides have been implanted in patients in the United	View HTML Integra LifeSciences announces 1000th implant of NeuraGenÔ Nerve Guide for Peripheral Nerve Repair 12.1 KB
Toggle SummaryApr 30, 2003	Positive Results Of DuraGen® Dural Graft Matrix Clinical Experience Involving 169 Patients Presented At AANS 2003 Annual Meeting In San Diego Positive Results Of DuraGen® Dural Graft Matrix Clinical Experience Involving 169 Patients Presented At AANS 2003 Annual Meeting In San Diego Plainsboro, New Jersey, April 29, 2003-- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that Dr. Peter D.	View HTML Positive Results Of DuraGen® Dural Graft Matrix Clinical Experience Involving 169 Patients Presented At AANS 2003 Annual Meeting In San Diego 12.1 KB
Toggle SummaryMay 5, 2003	Integra LifeSciences Announces Launch of New and Improved External Ventricular Drainage System Integra LifeSciences Announces Launch of New and Improved External Ventricular Drainage System Plainsboro, New Jersey, May 1, 2003-Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced the release of a new and improved Hermetic PlusT external ventricular drainage system (EVD).	View HTML Integra LifeSciences Announces Launch of New and Improved External Ventricular Drainage System 10.8 KB
Toggle SummaryJun 9, 2003	Court Upholds Integra LifeSciences Patents Court Upholds Integra LifeSciences Patents Finding of Infringement by Merck KGaA upheld; Case Remanded For New Damages Calculation Plainsboro, NJ /June 9, 2003 / -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that the United States Court of Appeals for the Federal	View HTML Court Upholds Integra LifeSciences Patents 12.1 KB
Toggle SummaryJul 22, 2003	Integra LifeSciences Schedules Conference Call for Thursday, July 31 to Discuss Second Quarter 2003 Financial Results and Update Forward-Looking Financial Guidance Integra LifeSciences Schedules Conference Call for Thursday, July 31 to Discuss Second Quarter 2003 Financial Results and Update Forward-Looking Financial Guidance PLAINSBORO, N.J.-July 22, 2003-- Integra LifeSciences Holdings Corporation (NASDAQ: IART - news) announced that it has scheduled a	View HTML Integra LifeSciences Schedules Conference Call for Thursday, July 31 to Discuss Second Quarter 2003 Financial Results and Update Forward-Looking Financial Guidance 10.4 KB